Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Jul 1 2016

Full Issue

Doctors, Hospitals Received $6.49B From Pharmaceutical Industry, Device Makers Last Year

Physicians and teaching hospitals in the U.S. took in fees, educational services, meals and other services worth billions, according to required annual disclosures available through a Centers for Medicare & Medicaid Services' database. Nearly 2.3 percent of the transactions between doctors and drugmakers were related to opioids.

Stat: Drug And Device Makers Paid $6.5 Billion To Docs And Teaching Hospitals Last Year

Drug and device makers paid nearly $6.5 billion in payments to doctors and teaching hospitals last year, according to the latest figures released on Thursday from a federal database. And physicians or their family members held $1 billion in ownership or investment interest in those companies. (Silverman, 6/30)

Bloomberg: Drug, Device Makers Gave U.S. Doctors, Hospitals $6.49 Billion

U.S. doctors and teaching hospitals got $6.49 billion in research and speaking fees, food and other goods or services from drug, biotechnology and medical-device companies in 2015, according to an annual report by the government. The data released Thursday represent the second full year of disclosures from the industry, describing financial links with clinicians who prescribe and use their products. The amount paid by manufacturers is on par with 2014, when they made $6.43 billion in payments. (Chen and Tracer, 6/30)

New Orleans Times-Picayune: Louisiana Doctors 2nd In U.S. For Accepting Drug Company Payments, Reports Says

Doctors at Louisiana hospitals are more likely to accept payments from drug and medical device companies than their peers in almost every other state in the country, a new analysis by the news organization ProPublica has found. Only New Jersey, home to some of the country's biggest drug companies, had a higher rate of doctors who took payments. (Lipinski, 6/30)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, July 21
  • Monday, July 20
  • Friday, July 17
  • Thursday, July 16
  • Wednesday, July 15
  • Tuesday, July 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF